Skip to content
  • Sunday, 26 July 2026
  • 4:31 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • FUJIFILM Cellular Dynamics Inaugurates State-of-the-Art Induced Pluripotent Stem Cell Manufacturing Facility in Madison, Wisconsin
Pharmaceutical R&D

FUJIFILM Cellular Dynamics Inaugurates State-of-the-Art Induced Pluripotent Stem Cell Manufacturing Facility in Madison, Wisconsin

Teuku Ryan May 22, 2026 0

FUJIFILM Cellular Dynamics has officially opened its new headquarters and a cutting-edge induced pluripotent stem cell (iPSC) manufacturing facility in…

Read More
Pharmaceutical R&D

Pharma Manufacturing Facility Sales to Outsourcers Signal Growing Industry Demand for Strategic Flexibility

Teuku Ryan May 12, 2026 0

A notable surge in the acquisition of pharmaceutical manufacturing facilities by contract development and manufacturing organizations (CDMOs) has illuminated a…

Read More
Pharmaceutical R&D

Novartis Breaks Ground on New Radioligand Therapy Manufacturing Facility in Denton, Texas, Bolstering US Healthcare Infrastructure

Teuku Ryan May 9, 2026 0

Novartis has commenced construction on a significant new radioligand therapy (RLT) manufacturing facility in Denton, Texas, a pivotal development in…

Read More
Pharmaceutical R&D

Apnimed Secures Up to $150 Million in Credit Facility to Fuel Potential US Launch of Obstructive Sleep Apnea Therapy AD109

Teuku Ryan Apr 7, 2026 0

Boston, MA – – Apnimed, a clinical-stage biopharmaceutical company focused on developing novel therapies for sleep-related breathing disorders, has announced…

Read More
Pioneering Minds Honored: The 2026 Al Yergey Mass Spectrometry Scientist Award Celebrates Innovation and MentorshipMonash University and ClinChoice Forge Strategic Alliance to Accelerate Therapeutic Development and Enhance Patient Access to Novel TreatmentsFUJIFILM Biotechnologies COO Maja Herold Pedersen on AI, autonomy and the path from quality to operationsYale Led Research Uncovers Molecular Mechanism Blocking Fertilization Offering New Paths for Infertility and Contraceptive Science
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ